• EZ Cap™ EPO mRNA (ψUTP): Assay Guide

  2026-10-01

  A scenario-based guide to using human erythropoietin mRNA in mammalian viability, proliferation, cytotoxicity, and neurorepair workflows. It explains how SKU R1020 supports controlled interpretation through Cap 1 capping, ψUTP modification, a poly(A) tail, defined concentration, and careful handling.

• Linoleic Acid C3108: Protocol and QC Guide

  2026-10-01

  Linoleic Acid C3108 provides a defined omega-6 fatty acid input for oxidative stress, membrane, erythrocyte, migration, and nutritional deficiency workflows. It is appropriate for solvent-controlled in vitro and animal research, but not for water-only protocols, long-term solution storage, or clinical and diagnostic validation.

• Isradipine (Dynacirc) Research Workflows

  2026-09-30

  Isradipine (Dynacirc) provides a practical way to interrogate L-type calcium signaling in vascular, cardiac, and neuronal models. This guide connects concentration planning, electrophysiology, calcium imaging, and tissue assays with controls that help distinguish genuine L-type effects from broader calcium-channel pharmacology.

• 3X FLAG Peptide: From Tagging to Translation

  2026-09-30

  A mechanistic and strategic guide to using the 3X (DYKDDDDK) Peptide for recombinant protein purification, immunodetection, structural biology, and translational assay development.

• Thapsigargin: SERCA Pump Inhibitor Workflow

  2026-09-29

  Use Thapsigargin to create a controlled, time-resolved disruption of intracellular calcium homeostasis for calcium imaging, endoplasmic reticulum stress research, and apoptosis assays. This workflow emphasizes dose-ranging, rapid endpoint capture, and controls that distinguish calcium signaling effects from nonspecific toxicity.

• Imipramine at the Autophagy–Lipid Interface

  2026-09-29

  Imipramine is best known as a tricyclic antidepressant, but its research value extends into autophagy, apoptosis, neurobiology, and immune signaling. This thought-leadership article connects those properties with lipidomic evidence showing that ceramide remodeling and autophagy support red-spotted grouper nervous necrosis virus replication. The result is a disciplined framework for testing Imipramine as a mechanistic probe—without confusing cross-domain hypothesis generation with validated antiviral or clinical efficacy.

• Thapsigargin Workflows for Calcium and ER Stress

  2026-09-28

  Build controlled calcium-signaling, ER-stress, and apoptosis experiments with Thapsigargin, a potent SERCA pump inhibitor. This guide connects rapid live-cell calcium measurements with mechanistic glioblastoma assays, practical dose design, and troubleshooting strategies.

• Alternariol: Workflows for Liver Toxicity Research

  2026-09-28

  Use Alternariol (AOH) to connect foodborne mycotoxin exposure with measurable hepatic-cell responses, from stellate-cell activation to apoptosis and metabolism. This guide turns emerging evidence into practical assay workflows, controls, and troubleshooting steps while separating suggested starting conditions from published findings.

• Dihydroartemisinin: Practical Research Workflows

  2026-09-27

  Build reproducible Dihydroartemisinin experiments with practical guidance for compound handling, dose-response design, and pathway validation. A malaria study provides a useful assay-design framework—but not evidence that its separate test compound’s results apply to Dihydroartemisinin.

• Tranexamic Acid Workflows for Clot-Stability Research

  2026-09-26

  Use Tranexamic Acid to separate clot formation from clot breakdown in biochemical, cell-based, and dressing-material experiments. A practical workflow connects concentration selection and fresh aqueous preparation with a 2024 clot-forming, antibacterial dressing study—without mistaking formulation results for the effect of Tranexamic Acid alone.

• Indazole and Indole Glucagon Receptor Antagonists

  2026-09-25

  A 2015 study extended the MK-0893 glucagon receptor antagonist series with indazole- and indole-based scaffolds, then explored structural variation and biological activity. Several compounds showed potent in vitro profiles and favorable rat pharmacokinetics; compound 16d also reduced glucagon-associated glucose elevation in acute human-receptor mouse models.

• Galectin-1 Impairs Hepatic Autophagy Through FIP200

  2026-09-25

  A 2026 study identifies galectin-1 as an inhibitor of hepatic autophagy that contributes to steatosis and insulin resistance through interaction with the autophagy scaffold FIP200. The findings connect a defined protein interaction to disrupted ULK-complex assembly and metabolic dysfunction, while pointing to questions that need testing in physiological disease models.

• 740 Y-P: PI 3-Kinase Activation in Cell Studies

  2026-09-24

  Use 740 Y-P to probe PI3K/AKT signaling in vesicular trafficking, cancer research, and neuronal cell survival assays. This guide distinguishes product-supported conditions from suggested starting protocols—and explains how to interpret PI3K activation alongside a study of stress-induced autophagy in bone marrow stromal cells.

• Tolazoline for α2-Receptor Assay Workflows

  2026-09-24

  Use Tolazoline to probe α2-adrenergic signaling in functional assays, then separate receptor-binding questions from downstream effects with a targeted concentration strategy. A part-coated capillary electrochromatography workflow offers a complementary route to affinity measurements—without implying that the published method directly validated Tolazoline.

• NVP-BGJ398 phosphate: FGFR Workflow Guide

  2026-09-23

  Use NVP-BGJ398 phosphate to connect FGFR1–3 target engagement with cellular and tissue-level phenotypes in biomarker-defined cancer models—and to test FGFR3 signaling in skeletal-disease research. This guide translates reported findings into a practical workflow, with controls and troubleshooting for interpreting pathway inhibition rather than relying on viability alone.

8477 records 1/566 page Next 12345 下5页 Last page